FundingWatcher
Home / Investors / Post IPO investors / Post IPO investors in Switzerland

Post IPO investors in Switzerland

Updated 16 Nov 2026

Reset

Venture funds

2 funds, by portfolio companies funded in the last 12 months
#FundSectorsStages LeadsFunded, 12 months
1 Nextech Invest
Nextech Invest is a venture capital and private equity firm spanning early to emerging growth stages, with recent companies Circle Pharma and Atavistik Bio.
Zürich, Switzerland
Health care, Biotech Early stage venture, Late stage venture 31% 2
2 Novartis Venture Fund
Novartis Venture Fund focuses on novel therapeutics and platforms, with recent investments in Hepalink and FoRx Therapeutics.
Basel, Switzerland
Health care, Biotech Seed, Early stage venture, Late stage venture 27% 2

Table 1. Post IPO investors in Switzerland: venture capital and micro VC funds ranked by companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.

Post IPO investors in Switzerland
One-time CSV
  • 26 firms, 26 with a website
  • 18 firm email addresses
  • 13 phone numbers
  • CRM-ready CSV, 15 columns
  • Download right after payment
With partner contacts
Compiled to order
  • The full list, plus the people who invest
  • Up to 2 partners per firm, compiled to order
  • Name, job title and LinkedIn where found
  • Verified direct email per person
  • List CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

investors-stage-post-ipo-investors-switzerland.csv26 rows × 15 columns
InvestorTypeLocationEmailPhone
Novartis Venture FundCorporate venture armBasel, Switzerland•••@sosei.com877 28•••
HBM Healthcare InvestmentsVenture capital firmZug, Switzerland•••@hbmhealthcare.com+41 41•••
UBSCorporate venture armZürich, Switzerland•••@ubs.com41 44 •••
VI PartnersVenture capital firmAltendorf, Switzerland•••@vipartners.ch+41 41•••
Nextech InvestVenture capital firmZürich, Switzerland•••@nextechinvest.com41 (0)•••
responsAbility Investments AGFund of fundsZürich, Switzerland•••@responsability.com+41 44•••
Partners GroupPrivate equity firmBaar, Switzerland•••@partnersgroup.com212 90•••
Pictet Private Equity Investors S.A.Investment bankGeneva, Switzerland•••@pictet.com

8 rows of the CSV in 5 of its 15 columns, email and phone masked.

26
Investors
18
With email
13
With phone
5
Active in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Post IPO investors in Switzerland

26 of 26, most investments first
26 rows
# Investor Type Location Invests in Latest portfolio companies Funded, 12 months Investments Lead Exits Email Phone LinkedIn
1 Novartis Venture Fund Corporate venture arm, Venture capital firm Basel, Switzerland Health care, Biotech Hepalink, FoRx Therapeutics 2 279 75 77 •••@sosei.com 877 28•••
2 HBM Healthcare Investments Venture capital firm Zug, Switzerland Biotech, Health care 4TEEN4 Pharmaceuticals, Sphingotec GmbH, Odyssey Therapeutics 260 47 90 •••@hbmhealthcare.com +41 41•••
3 UBS Corporate venture arm, Fund of funds Zürich, Switzerland Fintech, Hardware SWISSto12, MerQube, Nasdaq Private Market 3 157 53 53 •••@ubs.com 41 44 ••• In the CSV
4 VI Partners Venture capital firm Altendorf, Switzerland Health care, Biotech L.E.S.S. 1 111 26 22 •••@vipartners.ch +41 41••• In the CSV
5 Nextech Invest Venture capital firm Zürich, Switzerland Health care, Biotech Circle Pharma, Atavistik Bio 2 100 31 43 •••@nextechinvest.com 41 (0)••• In the CSV
6 responsAbility Investments AG Fund of funds, Private equity firm Zürich, Switzerland Fintech, Commerce Koa Switzerland, Investree, ePaylater 74 42 11 •••@responsability.com +41 44••• In the CSV
7 Partners Group Private equity firm Baar, Switzerland Hardware, Artificial intelligence Neara, Akur8, Sirion 74 39 34 •••@partnersgroup.com 212 90••• In the CSV
8 dRx Capital Corporate venture arm, Venture capital firm Basel, Switzerland Biotech, Health care Dopavision 31 4 8 In the CSV
9 Pictet Private Equity Investors S.A. Investment bank Geneva, Switzerland Artificial intelligence, Biotech Unique AI, Harbinger Health, Red Date Technology 30 4 6 •••@pictet.com In the CSV
10 Nice & Green SA Investment bank, Private equity firm Nyon, Switzerland 29 26 20 •••@nicengreen.ch In the CSV
11 Armada Investment AG Family office, Private equity firm Kusnacht, Switzerland Energy, Fintech Last Energy 1 19 5 5 •••@armada.com +41 44••• In the CSV
12 kineo finance Venture debt fund Basel, Switzerland 15 7 0 In the CSV
13 DDM Group Private equity firm Baar, Switzerland ClimateCamp 5 3 2 +41417••• In the CSV
14 CERN Government investment office, Pension fund Geneva, Switzerland 2 0 1 In the CSV
15 Genferberg Capital Private equity firm, Venture capital firm Zürich, Switzerland 2 0 1 •••@genferberg.ch +41 44•••
16 Corinth Investment Private equity firm, Venture capital firm Chur, Switzerland 1 1 1
17 Investment & Development One Holding SA Angel group, Family office Geneva, Switzerland 1 1 0 •••@id-oneholding.ch
18 Patrimonium Asset Management Private equity firm Crissier, Switzerland 1 1 1 +41 58••• In the CSV
19 Clearance Ventures Venture capital firm Basel, Switzerland 1 0 0 •••@clearanceventures.com +41 61••• In the CSV
20 FivazImmoInvestSARL Family office, Private equity firm Neuchâtel, Switzerland 0 0 0 •••@fivazimmoinvestsarl.com
21 Ibex Capital Partners Private equity firm Chatelaine, Switzerland 0 0 0 •••@ibexcap.ch In the CSV
22 Meye Asset Management Startup accelerator, Angel group Zürich, Switzerland 0 0 0 •••@managementasset.com
23 Odano Invest Family office, Private equity firm Cham, Switzerland 0 0 0
24 Private International Consulting Group Family office Chardonne, Switzerland 0 0 0 •••@private-int-consulting.com +41.22••• In the CSV
25 Samarjeet Das Ray Geneva, Switzerland 0 0 0 In the CSV
26 Top Swiss Investments Family office, Hedge fund Küsnacht, Switzerland 0 0 0 •••@top-invests.com

Table 2. Post IPO investors in Switzerland: the first 26 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 26.

Most active in the last 12 months

By portfolio companies funded
#InvestorLocation Funded, 12 monthsPortfolioLatest
1 UBS Zürich, Switzerland 3 26 SWISSto12, MerQube, Nasdaq Private Market
2 Nextech Invest Zürich, Switzerland 2 5 Circle Pharma, Atavistik Bio
3 Novartis Venture Fund Basel, Switzerland 2 20 Hepalink, FoRx Therapeutics
4 VI Partners Altendorf, Switzerland 1 19 L.E.S.S.
5 Armada Investment AG Kusnacht, Switzerland 1 2 Last Energy

Table 3. Post IPO investors in Switzerland: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Latest rounds in their portfolios

Newest first
Company What they do Sector Location Last round Amount Date Total raised Investors on this list Employees Founded
Circle Pharma Circle Pharma develops bioavailable macrocyclic peptide therapeutics that target protein-protein interactions. Biotech South San Francisco, United States Series E $92.5M 2026-09-16 $300.0M Nextech Invest 11 to 50 2012
SWISSto12 SWISSto12 designs, manufactures, and integrates radio frequency products for commercial and government customers. Hardware Renens, Switzerland Series C $70.0M 2026-07-16 $202.3M UBS 251 to 500 2011
MerQube MerQube provides technology for rules-based investment strategies and passive index design. Fintech San Francisco, United States Series C $30.0M 2026-04-13 $67.0M UBS 51 to 100 2019
Atavistik Bio Atavistik Bio develops precision allosteric small molecules to treat metabolic diseases and cancer. Biotech Cambridge, United States Series B $40.0M 2026-03-05 $260.0M Nextech Invest 11 to 50 2021
Nasdaq Private Market Nasdaq Private Market provides a marketplace where private companies, banks, brokers, and investors transact. Fintech San Francisco, United States Series C $37.6M 2026-01-16 $143.9M UBS 51 to 100 2013
FoRx Therapeutics FoRx Therapeutics is a biotechnology company developing cancer drugs that target DNA replication stress pathways. Biotech Basel, Switzerland Series A $50.0M 2025-12-18 $109.4M Novartis Venture Fund 11 to 50 2019
Last Energy Last Energy develops modular micro nuclear power plants to provide nuclear energy. Energy Austin, United States Series C $100.0M 2025-12-16 $164.0M Armada Investment AG 51 to 100 2019

Table 4. Post IPO investors in Switzerland: the 7 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.

Portfolio sectors

Portfolio sectorsCompaniesShare
Software 48 51%
Health care 35 37%
Biotech 31 33%
Fintech 24 25%
Hardware 18 19%
Artificial intelligence 16 17%
Education 3 3%
Commerce 3 3%
Cybersecurity 2 2%
Energy 2 2%

Table 5. Post IPO investors in Switzerland: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.

Investment stages

Table 6. Post IPO investors in Switzerland by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesInvestorsShare
Zürich 5 19%
Basel 4 15%
Geneva 4 15%
Baar 2 8%
Zug 1 4%
Altendorf 1 4%
Nyon 1 4%
Kusnacht 1 4%
Chur 1 4%
Crissier 1 4%
Neuchâtel 1 4%
Chatelaine 1 4%

Table 7. Post IPO investors in Switzerland by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Founded

FoundedInvestorsShare
2020s 1 4%
2010s 4 17%
2000s 11 46%
1990s 5 21%
1960s 1 4%
1950s 1 4%

Table 8. Post IPO investors in Switzerland by founding decade. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many post ipo investors in Switzerland are on the list?
26, in the file dated 16 November 2026. 5 of them invested in a company whose most recent round falls in the last 12 months.
How many have an email address?
18 of the 26 carry an email address in the download and 13 a phone number.
What does the CSV contain?
One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
How much does the list cost?
$29 one-time for all 26 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV with 26 rows, 18 firm email addresses and 13 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 12 of the 18 are inboxes such as info@ or contact@. No partner names.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Post IPO investors in Switzerland: 26 rows, CSV, $29 one-time.

At once: the CSV with 26 rows, 18 firm email addresses and 13 phone numbers, on the page after payment and by mail.

The emails are the address a firm publishes: 12 of the 18 are inboxes such as info@ or contact@. No partner names.

Columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.

With partner contacts: $199 one-time. List CSV right after payment; up to 2 verified partner emails per firm compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Other stages in Switzerland

Post IPO investors elsewhere

Cite: FundingWatcher, 26 post ipo investors in Switzerland, 16 November 2026. https://fundingwatcher.com/investors/stage/post-ipo-investors/switzerland/